A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China

Clinical trial NCT06346899 · COMPLETED

Trial details

NCT number: NCT06346899
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Hereditary Angioedema (HAE)

Start date: 2024-07-20
Primary completion: 2025-07-31
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.